Summit Medical has obtained the US Food and Drug Administration (FDA) clearance for the University of Minnesota's (U of M), US, jaw fracture device called Minne Ties Agile MMF.
Developed based on a research technology by former U of M senior innovation fellow Dr Alan Johnson, the device is designed for the non-invasive recovery of jaw fracture.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Minne Ties Agile features a collection of sutures that are inserted between the teeth to allow secure and even fixation of the jaw, and aiding proper recovery.
Summit Medical president Kevin McIntosh said: “It is extremely rewarding to be a part of a disruptive technology that is redefining the industry and making a positive impact on patients, surgeons and hospital teams.
“Working with the University of Minnesota and Dr Johnson on commercialising Minne Ties has been a thoroughly positive experience."
Unlike existing wire-based methods, which may cause abrasions on the lips and gums, and gingivitis, the new device’s sutures come with a smooth clasp head and a blunt tip to minimise gum irritation and dental hygiene concerns.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe sutures are claimed to enable quick and easy application with little discomfort.
Dr Johnson developed the Minne Ties technology in 2012, while it was later licenced for further development by Summit Medical in 2014.
Image: Minne Ties Agile MMF model. Photo: courtesy of Summit Medical Inc.
